Academically, socially, and institutionally, America has not yet recovered from COVID-19 on the fifth anniversary of ...
The U.S. Food and Drug Administration has reportedly targeted a manufacturer of poppers, an inhalant drug that has gained ...
Two judges ruled Thursday that President Donald Trump’s administration needs to reinstate thousands of federal workers it ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Most of those infections have been seen in wild bird populations, with two known instances of backyard poultry flocks ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.
Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Pharmaceutical Technology on MSN4d
Kenox and Lactiga partner on sIgA therapies for immunodeficiencyKenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback